Dr. Reddy's expected to post Q4 net profit of ₹1,040cr
NewsBytes | May 11, 2026 11:39 PM CST
Dr. Reddy's reports results May 12
The company will share its Q4 and full-year results on May 12.
Despite tough times in the US market and rising freight expenses, Dr. Reddy's is still pushing forward.
Just this March, they launched Obeda, India's first generic semaglutide for type 2 diabetes after getting the green light from DCGI.
READ NEXT
-
'Sheikh Mohamed had coffee at my house': How UAE President stays close to people
-
JoSAA Counselling 2026: How to Secure a Top NIT Even with a Low Rank? Simply Master This '50% Formula'..
-
NCW report alleges toxic culture and POSH failures at TCS Nashik unit
-
Priyanka Chopra's daughter Malti Marie guesses her 'mom's favourites' perfectly at four
-
New AI Tool Arrives on WhatsApp Business: Create Product Descriptions and Images in Minutes—Here's How to Use It..
